Neurology
Opinion
When’s the right time to use dementia as a diagnosis?
Conference Coverage
Statins crush early seizure risk poststroke
BANGKOK – Statin initiation upon hospitalization for acute ischemic stroke was linked to a major antiseizure benefit in a Japanese study.
News
Obesity tied to relapse in young patients with multiple sclerosis
Weight loss or BMI-based dosing might improve treatment response.
Conference Coverage
CDC: Look for early symptoms of acute flaccid myelitis, report suspected cases
The average age of a patient diagnosed with AFM is 5 years
Latest News
Metformin linked to lower dementia risk in black patients
Black patients younger than 75 years fared better on first-line metformin monotherapy than they did on sulfonylurea monotherapy.
News
Lipoprotein(a) levels tied to higher ischemic stroke risk
High levels of lipoprotein(a) [Lp(a)] and LPA genotypes were linked to increased ischemic stroke risk in a recent large, contemporary general...
News
Anticholinergic drugs linked to dementia in older populations
“Associations were stronger in [dementia] cases diagnosed before the age of 80 years,” the researchers noted.
News
Cognitive decline sped up after CHD
The acceleration in cognitive decline persisted for years after incident CHD.
News
Opioid prescriptions declined 33% over 5 years
The number of opioid prescriptions decreased 33% nationally from 2013 to 2018, according to the new report from the American Medical Association...
Conference Coverage
DOACs surpass warfarin in low-weight AFib patients
SAN FRANCISCO – Data from 21,000 Korean AFib patients weighing 60 kg or less showed DOACs had better efficacy and safety than did warfarin.